MediFind found 5 doctor with experience in Paroxysmal Nocturnal Hemoglobinuria (PNH) near Boulder, CO. Of these, 5 are Experienced.
Rocky Mountain Cancer Centers Llp
Mark Sitarik is a Hematologist Oncology specialist and a Hematologist in Boulder, Colorado. Dr. Sitarik has been practicing medicine for over 43 years and is rated as an Experienced provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). His top areas of expertise are Heyde Syndrome, Von Willebrand Disease (VWD), Paget Disease of the Breast, and Breast Cancer.
Rocky Mountain Cancer Centers Llp
Austin Poole is a Hematologist Oncology specialist and a Radiation Oncologist in Boulder, Colorado. Dr. Poole is rated as an Experienced provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). His top areas of expertise are Prostate Cancer, Colorectal Cancer, Familial Colorectal Cancer, and Familial Prostate Cancer.
Rocky Mountain Cancer Centers Llp
Gregory Britt is a Hematologist Oncology specialist and a Hematologist in Boulder, Colorado. Dr. Britt is rated as an Experienced provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). His top areas of expertise are Iron Deficiency Anemia, Hodgkin Lymphoma, Childhood Iron Deficiency Anemia, and Hemochromatosis.
Rocky Mountain Cancer Centers Llp
David Andorsky is a Hematologist Oncology specialist and a Hematologist in Boulder, Colorado. Dr. Andorsky is rated as an Experienced provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). His top areas of expertise are Follicular Lymphoma, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), and Richter Syndrome.
Rocky Mountain Cancer Centers Llp
Laurie Shumaker is a Nurse Practitioner in Boulder, Colorado. Ms. Shumaker is rated as an Experienced provider by MediFind in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). Her top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), and Febrile Neutropenia.
Last Updated: 10/30/2025